Tempest Therapeutics Statistics

Total Valuation

TPST has a market cap or net worth of $28.20 million. The enterprise value is $19.88 million.

Market Cap	28.20M
Enterprise Value	19.88M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TPST has 4.09 million shares outstanding. The number of shares has increased by 91.15% in one year.

Current Share Class	4.09M
Shares Outstanding	4.09M
Shares Change (YoY)	+91.15%
Shares Change (QoQ)	+9.01%
Owned by Insiders (%)	0.16%
Owned by Institutions (%)	3.75%
Float	3.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.24
P/TBV Ratio	2.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 1.18.

Current Ratio	1.70
Quick Ratio	1.63
Debt / Equity	1.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-40.57

Financial Efficiency

Return on equity (ROE) is -282.07% and return on invested capital (ROIC) is -86.20%.

Return on Equity (ROE)	-282.07%
Return on Assets (ROA)	-73.47%
Return on Invested Capital (ROIC)	-86.20%
Return on Capital Employed (ROCE)	-236.94%
Revenue Per Employee	n/a
Profits Per Employee	-$1.87M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.72% in the last 52 weeks. The beta is -2.33, so TPST's price volatility has been lower than the market average.

Beta (5Y)	-2.33
52-Week Price Change	-74.72%
50-Day Moving Average	7.02
200-Day Moving Average	11.03
Relative Strength Index (RSI)	50.06
Average Volume (20 Days)	245,542

Short Selling Information

The latest short interest is 439,554, so 10.75% of the outstanding shares have been sold short.

Short Interest	439,554
Short Previous Month	111,173
Short % of Shares Out	10.75%
Short % of Float	11.53%
Short Ratio (days to cover)	2.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-44.99M
Pretax Income	-31.75M
Net Income	-44.80M
EBITDA	-44.62M
EBIT	-44.99M
Earnings Per Share (EPS)	-$17.38

Full Income Statement

Balance Sheet

The company has $21.51 million in cash and $13.11 million in debt, giving a net cash position of $8.41 million or $2.06 per share.

Cash & Cash Equivalents	21.51M
Total Debt	13.11M
Net Cash	8.41M
Net Cash Per Share	$2.06
Equity (Book Value)	11.13M
Book Value Per Share	3.16
Working Capital	9.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$33.88 million and capital expenditures -$267,000, giving a free cash flow of -$34.14 million.

Operating Cash Flow	-33.88M
Capital Expenditures	-267,000
Free Cash Flow	-34.14M
FCF Per Share	-$8.35

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-91.15%
Shareholder Yield	-91.15%
Earnings Yield	-158.38%
FCF Yield	-120.71%

Analyst Forecast

The average price target for TPST is $30.00, which is 334.78% higher than the current price. The consensus rating is "Hold".

Price Target	$30.00
Price Target Difference	334.78%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-24.59%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 9, 2025. It was a reverse split with a ratio of 0.0769231:1.

Last Split Date	Apr 9, 2025
Split Type	Reverse
Split Ratio	0.0769231:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1